beta-catenin (S33Y)-pcw107-V5 Citations (2)

Originally described in: Systematic identification of signaling pathways with potential to confer anticancer drug resistance.
Martz CA, Ottina KA, Singleton KR, Jasper JS, Wardell SE, Peraza-Penton A, Anderson GR, Winter PS, Wang T, Alley HM, Kwong LN, Cooper ZA, Tetzlaff M, Chen PL, Rathmell JC, Flaherty KT, Wargo JA, McDonnell DP, Sabatini DM, Wood KC Sci Signal. 2014 Dec 23;7(357):ra121. doi: 10.1126/scisignal.aaa1877. PubMed Journal

---

Articles Citing beta-catenin (S33Y)-pcw107-V5

Articles
Melanoma Suppressor Functions of the Carcinoma Oncogene FOXQ1. Bagati A, Bianchi-Smiraglia A, Moparthy S, Kolesnikova K, Fink EE, Lipchick BC, Kolesnikova M, Jowdy P, Polechetti A, Mahpour A, Ross J, Wawrzyniak JA, Yun DH, Paragh G, Kozlova NI, Berman AE, Wang J, Liu S, Nemeth MJ, Nikiforov MA. Cell Rep. 2017 Sep 19;20(12):2820-2832. doi: 10.1016/j.celrep.2017.08.057. PubMed
Beta-Catenin Mutations Can Impact on the Interplay Between Tumor and Immune Cells and Hepatic Microbiota in Hepatocellular Cancer. Ota Y, Driscoll J, Hill AR, Yan IK, Patel T. J Hepatocell Carcinoma. 2025 Aug 1;12:1677-1693. doi: 10.2147/JHC.S524341. eCollection 2025. PubMed

If you have published an article using this material, please email us at to have your article added to this page.